Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1997 Jul;88(7):625–629. doi: 10.1111/j.1349-7006.1997.tb00428.x

Reduced Expression of Cyclin–dependent Kinase Inhibitor p27Kipl Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas

Wataru Yasui 1, Yasusei Kudo 1, Shuho Semba 1, Hiroshi Yokozaki 1, Eüchi Tahara 1,✉
PMCID: PMC5921483  PMID: 9310133

Abstract

Reduced expression of a cyclin–dependent kinase inhibitor p27Kipl has recently been shown to predict poor survival of patients with breast and colorectal cancers. We studied the expression of p27Kipl in gastric carcinomas by northern blotting, western blotting and immunohistochemistry to determine whether lack of p27 has implications for aggressiveness of gastric cancer. Reduced expression of p27 was detected in 40% of the gastric carcinomas at the mRNA level, while it was detected in 57% at the protein level. No gross alterations of the p27 gene were observed in any of the cases examined by Southern blot analysis. Inimunohistochemical studies revealed that the expression of p27 was well preserved in most of the gastric adenomas, whereas it was so in only 26% of the gastric carcinomas. Fifty–six percent of the carcinomas showed almost no p27–positive cells. Decrease of p27–positive cells significantly correlated with advanced stage, depth of tumor invasion and lymph node metastasis. The expression of p27 showed an inverse correlation with the expression of cyclin E. These findings suggest that reduction of p27Klpl protein may reflect the progression of gastric carcinomas and may be an indicator of high–grade malignancy.

Keywords: CDK inhibitor, p27Klpl, Gastric carcinoma, Northern blotting, Immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (365.4 KB).

REFERENCES

  • 1. ) Sherr , C. J.GI phase progression: cycling on cue . Cell , 79 , 515 – 555 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Hunter , T. and Pines , J.Cyclins and cancer II: cyclin D and CDK inhibitors come of age . Cell , 79 , 573 – 582 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Akama , Y. , Yasui , W. , Yokozaki , H. , Kuniyasu , H. , Kitahara , K. , Ishikawa , T. and Tahara , E.Frequent amplification of the cyclin E gene in human gastric carcinomas . Jpn. J. Cancer Res. , 86 , 617 – 621 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Yasui , W. , Akama , Y. , Kuniyasu , H. , Yokozaki , H. , Shimamoto , F. and Tahara , E.Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status . J. Exp. Ther. Oncol. , 1 , 88 – 94 ( 1996. ). [PubMed] [Google Scholar]
  • 5. ) Harper , J. W. , Adami , G. R. , Wei , N. , Keyomarsi , K. and Elledge , S. J.The p21 Cdk‐interacting protein Cip1 is a potent inhibitor of G1 cyclin‐dependent kinases . Cell , 75 , 805 – 816 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Polyak , K. , Kato , J. , Solomon , M. J. , Sherr , C. J. , Massague , J. , Roberts , J. M. and Koff , A.p27Kipl, a cyclin‐Cdk inhibitor, links transforming growth factor‐Cdk and contact inhibition to cell cycle arrest . Gene Dev. , 8 , 9 – 22 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Polyak , K. , Lee , M.‐H. , Erdjument‐Bromage , H. , Koff , A. J. , Roberts , J. M. , Tempst , P. and Massague , J.Cloning of p27Klpl, a cyclin‐dependent kinase and a potent mediator of extracellular antimitogenic signals . Cell , 78 , 59 – 66 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Toyoshima , H. and Hunter , T.p27, a novel inhibitor of G1 cyclin‐Cdk protein kinase activity, is related to p21 . Cell , 78 , 67 – 74 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Nobori , T. , Miura , K. , Wu , D. J. , Lois , A. , Takabayashi , K. and Carson , D. A.Deletions of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers . Nature , 368 , 753 – 756 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 10. ) Serrano , M. , Hannon , G. J. and Beach , D.A new regulatory motif in cell‐cycle control causing specific inhibition of cyclin D/CDK4 . Nature , 366 , 704 – 707 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Kuniyasu , H. , Yasui , W. , Kitahara , K. , Naka , K. , Yokozaki , H. , Akama , Y. , Hamamoto , T. , Tahara , H. and Tahara , E.Growth inhibitory effect of interferon‐β is associated with the induction of cyclin‐dependent kinase inhibitor p27Kipl in a human gastric carcinoma cell line . Cell Growth Differ. , 8 , 47 – 52 ( 1997. ). [PubMed] [Google Scholar]
  • 12. ) Ponce‐Castaneda , M. V. , Lee , M.‐H. , Latres , E. , Polyak , K. , Lacombe , L. , Montgomery , K. , Mathew , S. , Krauter , K. , Sheinfeld , J. , Massague , J. and Cordon‐Cardo , C.p27Kipl: chromosomal mapping to 12p12‐12p13.1 and absence of mutations in human tumors . Cancer Res , 55 , 1211 – 1214 ( 1995. ). [PubMed] [Google Scholar]
  • 13. ) Kawamata , R , Morosetti , R. , Miller , C. W. , Park , D. , Spirin , K. S. , Nakamaki , T. , Takeuchi , S. , Hatta , Y. , Simpson , J. , Wilczynski , S. , Lee , Y. Y. , Bartram , C. R. and Koeffler , H. P.Molecular analysis of the cyclin‐dependent kinase inhibitor gene p27/Kipl in human malignancies . Cancer Res. , 55 , 2266 – 2269 ( 1995. ). [PubMed] [Google Scholar]
  • 14. ) Porter , P. L. , Malone , K. E. , Heagerty , P. J. , Alexander , G. M. , Gatti , L. A. , Firpo , E. J. , Baling , J. R. and Roberts , J. M.Expression of cell‐cycle regulators p27Klpl and cyclin E, alone and in combination, correlates with survival in young breast cancer patients . Nat. Med. , 2 , 222 – 225 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Catzavelos , C. , Bhattacharya , N. , Ung , Y. C. , Wilson , J. A. , Roncari , L. , Sandhu , C. , Shaw , P. , Yeger , H. , Morava‐Protzner , L , Kapusta , L. , Franssen , E. , Pritchard , K. I. and Slingerland , J. M.Decreased levels of the cell‐cycle inhibitor p27Klpl protein: prognostic implications in primary breast cancer . Nat. Med. , 2 , 227 – 230 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Loda , M. , Cukor , B. , Tarn , S. W. , Lavin , P. , Florentine , M. , Draetta , G. F. , Jessup , J. M. and Pagano , M.Increased proteasome‐dependent degradation of the cyclin‐dependent kinase inhibitor p27 in aggressive colorectal carcinomas . Nat. Med. , 2 , 231 – 234 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Japanese Research Society for Gastric Cancer . “Japanese Classification of Gastric Carcinoma ,” 1st English ed. ( 1995. ). Kanehara Co. , Tokyo . [Google Scholar]
  • 18. ) Yasui , W. , Kuniyasu , H. , Yokozaki , H. , Semba , S. , Shimamoto , F. and Tahara , E.Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki‐67 and p53 protein . Virchows Arch. , 429 , 13 – 19 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Hengst , L. and Reed , S.Translational control of p27Kipl accumulation during the cell cycle . Science , 271 , 1861 – 1864 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Yasui , W. , Akama , Y. , Kuniyasu , H. , Yokozaki , H. , Semba , S. , Shimamoto , F. and Tahara , E.Expression of cyclin‐dependent kinase inhibitor p21WAF1/CIP1 in non‐neoplastic mucosa and neoplasia of the stomach: relation with p53 status and proliferative activity . J. Pathol. , 180 , 122 – 128 ( 1996. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES